- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- January 2026
Global
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
North America
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
Europe
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
Middle East
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
Asia Pacific
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
United States
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
United Kingdom
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
China
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
Europe
From €3558EUR$3,990USD£3,086GBP
- Report
- January 2026
United Kingdom
From €3558EUR$3,990USD£3,086GBP
Prostaglandins are a class of hormones that play a role in endocrine and metabolic disorders. They are involved in a variety of physiological processes, including inflammation, blood pressure regulation, and cell growth. Prostaglandins are used to treat a range of endocrine and metabolic disorders, including diabetes, obesity, and thyroid disorders. They are also used to treat conditions such as asthma, arthritis, and ulcers. Prostaglandins are available in both oral and injectable forms, and can be used in combination with other drugs to treat more complex conditions.
The prostaglandin market is a rapidly growing sector of the pharmaceutical industry. Companies are investing heavily in research and development to develop new and improved prostaglandin-based treatments. Some of the major players in the prostaglandin market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Other companies such as Sanofi, AstraZeneca, and Bayer are also active in the prostaglandin market. Show Less Read more